With regard to pharmaceutical drugs, treatments and therapies authorized by Health Canada since January 1, 2022: (a) how many treatments or therapies for rare diseases, known as orphan drugs, were granted authorization; and (b) what are the details of each drug in (a), including the (i) name of the drug, (ii) date of the approval, (iii) purpose of the drug, including the disease or condition treated by the drug?
In the House of Commons on April 17th, 2023. See this statement in context.